Highights the immunophenotypic and molecular genetic tests of greatest value in diagnoses, risk assessment, and disease monitoring. The focus on molecular genetic findings for each neoplasm parallels the ever-expanding role of genetics in disease classification and risk assessment. Key problem areas and differential diagnostic considerations are also included for each neoplastic disease category.